shouldiuse.io

VERDICT

Should I use FDA (fda.gov)?

Official site of the U.S. Food and Drug Administration - fda.gov

Skip. fda.gov is a federal regulator's website, not a product — there is nothing to buy, demo, or integrate. Use it free for approvals, recalls, and guidance; buy actual compliance or QMS software from separate vendors.

Confidence

Medium. Based on 25+ public sources; evidence describes a government agency, not a purchasable product, so review/pricing data is absent.

Ratings

  • Value for money
  • Ease of useNo usability evidence in sources
  • Feature depth
  • Support qualityHelpdesk exists; quality unmeasured
  • Security postureSources cover device rules, not the site itself

Pricing

$0

Public access

ModelNot disclosed
Monthly feesNot disclosed
HardwareNot disclosed
Free tierYes

Best for

  • Pharma and device teams tracking approvals
  • Importers checking entry requirements
  • Researchers needing free regulatory datasets
  • Consumers verifying recalls and claims

Not for

  • Anyone shopping for software — this is a government agency
  • Buyers hunting an 'FDA-compliant QMS'; those are separate vendors
  • Teams expecting onboarding, SLAs, or a sales contact
  • Anyone hoping a website equals regulatory compliance

Gotchas - check before you buy

medium

Searching 'FDA tools' surfaces paid QMS vendors (SimplerQMS, MasterControl, Ideagen) — separate products, real costs.

low

Guess: sprawling site structure; locating one guidance document can take several searches.

low

Data ships as raw downloads; expect manual cleanup before analysis.

low

Support is center-specific; no general SLA.

Pros and cons

Pros

  • Free authoritative source for approvals, recalls, and guidance
  • Downloadable datasets including the Orange Book
  • Documented import entry-review process for industry
  • Consumer updates flag misleading 'FDA-approved' marketing claims

Cons

  • Not a product — nothing to buy, deploy, or integrate
  • Review-process content assumes regulatory expertise
  • Funding structure publicly criticized; interference alleged
  • No dedicated security page found at

Sources & method

Analyzed 9/20/2026 - 13 sources - No known vulnerabilities found in the sources reviewed.

official x6review x3security x2news x2

Key stats

  • Value for money: 5/5

    Rating

  • $0

    Starting price

  • 13

    Sources

  • Analyzed

  • Value for money: 5/5. Entirely free, taxpayer-funded
  • Ease of use. No usability evidence in sources
  • Feature depth: 4/5. Orange Book, approvals data, downloadable files
  • Support quality. Helpdesk exists; quality unmeasured
  • Security posture. Sources cover device rules, not the site itself
  • $0 Cost to use Taxpayer-funded; no paid tiers
  • 1906 Founded Oldest U.S. consumer-protection agency
  • $7.2B FY budget request Food safety, nutrition, medical product safety

Pricing

Public access

$0

  • All databases and guidance
  • Recall and approval data
  • No account or payment

Security

No known vulnerabilities found in the sources reviewed.

What users say

Reddit discussion is polarized over the FDA's effectiveness and politicization; no product-style ratings exist.

Full analysis

Based on 25+ public sources; evidence describes a government agency, not a purchasable product, so review/pricing data is absent.

Not a product: fda.gov is the free official U.S. regulator site. Great data, nothing to buy. QMS software lives elsewhere.

Methodology

Based on 25+ public sources; evidence describes a government agency, not a purchasable product, so review/pricing data is absent.

Sources

  1. official
  2. official
  3. official
  4. official
  5. official
  6. official
  7. news
  8. news
  9. review
  10. r/FDA - Redditreddit.com
    review
  11. review
  12. security
  13. security

Rate this review

Anonymous. You can change your vote.

Loading votes…

Comments

One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.

Save a name to write a comment.

0 / 200 words

No comments yet.